Federal Register / Vol. 66, No. 125 / Thursday, June 28, 2001 / Notices 34449

and qualified agency to provide the

services specified under this

cooperative agreement because:

PAHO coordinates international

health activities for countries and

territories of Latin America and the

Caribbean. Their access to member

States (Latin American and Caribbean

countries) and their public health

programs is unique in this region.

PAHO has the lead in advancing

environmental public health in Latin

America and the Caribbean. PAHO is

the only organization serving Latin

America and the Caribbean with a focus

on the health impact of agricultural and

industrial development. PAHO provides

epidemiologic and toxicologic risk

assessment and support required for the

prevention of health risks associated

with toxic wastes and their air and

water pollution byproducts, food

contamination, and other environmental

health and occupational hazards and

diseases.

PAHO has long standing expertise in

regional disease surveillance,

application of technology in different

settings, development of training

methods for health personnel, use of

research to clarify and resolve health

problems, and integration of different

health programs to achieve maximum

efficiency and effectiveness.

The proposed program is strongly

supportive of and directly related to the

achievement of PAHO and CDC/

National Center for Environmental

Health (NCEH) and Office on Smoking

and Health (OSH) research,

development, and implementation

programs in environmental health

epidemiology, surveillance, and

prevention.

Note: Title 2 of the United States Code,

Chapter 26, Section 1611 states that an

organization described in Section 501(c) of

the Internal Revenue Code of 1986 that

engages in lobbying activities is not eligible

to receive Federal funds constituting an

award, grant, cooperative agreement,

contract, loan, or any other form.

C. Availability of Funds

Approximately $499,300 is available

in FY 2001 to support this program. It

is expected that the award will begin on

September 30, 2001, and will be made

for a 12-month budget period within a

project period of up to five years.

Funding estimates may change.

Continuation awards within an

approved project period will be made

on the basis of satisfactory progress as

evidenced by required reports and the

availability of funds.

D. Where to Obtain Additional

Information

To obtain business management

technical assistance, contact: Sharron

Orum, Lead, Grants Management

Specialist, Grants Management Branch,

Procurement and Grants Office, Centers

for Disease Control and Prevention,

2920 Brandywine Road, Room 3000,

Atlanta, GA 30341–4146, Telephone

number: (770) 488–2716, Email address:

spo2@cdc.gov.

For program technical assistance,

contact: Michael A. McGeehin, PhD,

MSPH Director, Division of

Environmental Hazards and Health

Effects, National Center for

Environmental Health, 6 Executive Park

Drive, Atlanta, GA 30329, Telephone

number: (404) 498–1300, Email address:

Mmcgeehin@cdc.gov.

Dated: June 22, 2001.

John L. Williams,

Director, Procurement and Grants Office,

Centers for Disease Control and Prevention

(CDC).

[FR Doc. 01–16246 Filed 6–27–01; 8:45 am]

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

[Program Announcement 01111]

Global Malaria Prevention and Control

Notice of Availability of Funds

A. Purpose

The Centers for Disease Control and

Prevention (CDC) announces the

availability of fiscal year (FY) 2001

funds for a cooperative agreement

program for Global Malaria Prevention

and Control. This program addresses the

‘‘Healthy People 2010’’ focus areas of

Immunization and Infectious Diseases.

The purpose of the program is to

expand the involvement of

organizations in the global Roll Back

Malaria (RBM) effort and to foster

endemic-country action in malaria

prevention and control program

implementation and the relevant

ancillary activities (e.g., baseline

evaluation, strategy development,

training, monitoring and evaluation,

focused operations research to further

the program implementation). See

Attachment 2 for more background

information.

B. Eligible Applicants

Assistance will be provided to public

and private nonprofit organizations and

their agents, including public and

nonprofit faith-based organizations.

Note: Title 2 of the United States Code,

Chapter 26, Section 1611 states that an

organization described in section 501(c)(4) of

the Internal Revenue Code of 1986 that

engages in lobbying activities is not eligible

to receive Federal funds constituting an

award, grant, cooperative agreement,

contract, loan, or any other form.

C. Availability of Funds

Approximately $500,000 is available

in FY 2001 to fund approximately three

awards. It is expected that the average

award will be $125,000, ranging from

$100,000 to $150,000. It is expected that

the awards will begin on or about

September 30, 2001, and will be made

for a 12-month budget period within a

project period of up to three years.

Funding estimates may change.

Continuation awards within an

approved project period will be made

on the basis of satisfactory progress as

evidenced by required reports and the

availability of funds.

Funding Preference

Funding preference will be given to

organizations proposing to work in subSaharan African countries with the

greatest number of malaria deaths.

D. Program Requirements

In conducting activities to achieve the

purpose of this program, the recipient

will be responsible for the activities

under 1. (Recipient Activities), and CDC

will be responsible for the activities

listed under 2. (CDC Activities).

1. Recipient Activities

The applicant and their partner(s) in

the malaria-endemic country must:

a. Enhance local capacity for

implementing methods that will reduce

malaria transmission and the morbidity

and mortality from malaria infection in

the partner malaria-endemic country.

Applicants, in collaboration with the

partner country, should analyze the

partner country’s current infrastructure

for RBM implementation (per

Attachment 3) and develop strategies

that will address the priority

implementation needs. In countries

where such an analysis has already been

done, applicants should propose to

carry out through collaboration with a

partner organization in the partner

country the priority malaria prevention

activities identified through the

infrastructure analysis.

Priority program areas are listed

below and are examples of activities

that would be appropriate to propose

under this announcement. Some of

these activities may have been

34450 Federal Register / Vol. 66, No. 125 / Thursday, June 28, 2001 / Notices

addressed or are currently being

addressed by the partner country’s

government or other partner

organizations, in which case, the

applicant should not duplicate existing

efforts. Details and example activities

for each are provided as attachments in

the application kit.

1. Public health capacity building for

government or institutions contributing

to malaria prevention and control

(Attachment 4)

2. Increase the public’s access to

effective antimalarial drugs and

appropriate management of malaria

illness to reduce malaria-associated

mortality or the severity and duration of

malaria illness. (Attachment 5)

3. Reduce exposure to malaria,

particularly among young children and

pregnant women, through the use of

proven malaria control interventions.

(Attachment 6)

4. Prevention of malaria and its

adverse consequences during

pregnancy. (Attachment 7)

5. Assess RBM program progress

(Attachment 8)

6. Operations research (Attachment 9)

b. Attend and participate in an annual

meeting of grantee representatives to

present, discuss, and evaluate program

activities.

c. If a proposed project involves

research on human participants, ensure

appropriate Independent Review Board

(IRB) review.

2. CDC Activities

a. Provide consultation and assistance

with training curricula and materials as

necessary and appropriate for incountry training programs.

b. Provide consultation and assistance

as needed to further the efforts of

cooperative agreement recipients and

their country partners in RBM planning

and assessment.

c. Provide consultation and assistance

on methods for treatment of malaria,

enhancing local capacity to increase use

of insecticide treated bed nets, or

prevention of malaria and its adverse

consequences during pregnancy.

d. Provide consultation and assistance

on operations research study designs

that may be carried out by one or more

cooperative agreement recipients.

e. Assist in the development of a

research protocol for IRB by all

cooperating institutions participating in

the research project. The CDC IRB will

review and approve the protocol

initially and on at least an annual basis

until the research project is completed.

f. Participate in an annual meeting of

grantee representatives to present,

discuss, and evaluate program activities.

E. Content

Letter of Intent (LOI)

An LOI is requested for this program.

The narrative should be no more than

two single-spaced pages, printed on one

side, with one inch margins, and

unreduced font. Your letter of intent

will be used to plan the independent

review group. The letter should include

the following information (1) name and

address of the organization and the

proposed partner country and

organization(s); (2) name, address and,

telephone number of a contact person;

(3) a brief description of the past and

anticipated collaboration between the

applicant and partner organization(s) in

the partner country.

Applications

Use the information in the Program

Requirements, Other Requirements, and

Evaluation Criteria sections to develop

the application content. Your

application will be evaluated on the

criteria listed, so it is important to

follow them in laying out your program

plan.

Applicants must include evidence

that they have notified the appropriate

agency or Ministry of Health (MOH) in

the government of the international or

partner country. Applicant must receive

concurrence from the appropriate

agency or MOH in the government

before an official award is made.

Applicants must show an established

relationship with a partner

organization(s) in the country they

propose for their project. A letter with

the partner’s letterhead documenting

the partner’s agreement to collaborate

on the respective activities must be

included after the face page of the

application. Without this letter(s), the

application will be deemed nonresponsive and returned.

F. Submission and Deadline

Letter of Intent (LOI)

On or before July 15, 2001 submit the

LOI to the Grants Management

Specialist identified in the ‘‘Where to

Obtain Additional Information’’ section

of this announcement.

Application

Submit the original and five copies of

PHS–398 (OMB Number 0925–0001)

(adhere to the instructions on the Errata

Instruction Sheet for PHS 398). Forms

are available in the application kit and

at the following Internet address:

www.cdc.gov/od/pgo/forminfo.htm.

On or before August 13, 2001, submit

the application to the Grants

Management Specialist identified in the

‘‘Where to Obtain Additional

Information’’ section of this

announcement.

Deadline: Applications shall be

considered as meeting the deadline if

they are either:

1. Received on or before the deadline

date; or

2. Sent on or before the deadline date

and received in time for submission to

the independent review group.

(Applicants must request a legibly dated

U.S. Postal Service postmark or obtain

a legibly dated receipt from a

commercial carrier or U.S. Postal

Service. Private metered postmarks shall

not be acceptable as proof of timely

mailing.)

Late: Applications which do not meet

the criteria in 1. or

2. above will be returned to the

applicant.

G. Evaluation Criteria

Each application will be evaluated

individually against the following

criteria by an independent review group

appointed by CDC.

1. Background and Need (15 Points)

a. The extent to which the malaria

situation in the partner malaria-endemic

country is well established as an

important cause of morbidity and

mortality across the country;

b. The extent to which the existing

malaria control program and its

prevention and control strategies are

clearly described;

c. The extent to which existing

surveillance, monitoring and evaluation

methods and capability are clearly

described;

d. The extent to which gaps and

priorities in malaria prevention and

control implementation are clearly

described.

2. Collaborative Arrangement(s) (25

Points)

a. The extent to which the description

of past and current collaboration

between the applicant and partner

organization in the partner country

reflects an effective working

relationship that will support the

proposed activities;

b. The extent to which the

collaboration will include the

organization responsible for policy and

implementation of malaria prevention

and control in the target area;

c. Formal letters of support are

provided for this application from

appropriate groups (Ministry of Health,

University, etc.) within the malariaendemic country to demonstrate the

appropriate and necessary cooperation

for malaria prevention and control

program support.

Federal Register / Vol. 66, No. 125 / Thursday, June 28, 2001 / Notices 34451

d. The extent to which plans for

representation at the annual meeting of

awardees reflect the intent to actively

collaborate with other awardees through

this meeting.

3. Plan of Operation (45 Points)

a. The extent to which the application

provides evidence that key personnel

have the ability and program skills to

develop and carry out the proposed

activities;

b. The extent to which the applicant

and malaria-endemic partners have

demonstrated a collaborative review of

the priority needs for malaria in the

malaria-endemic country;

c. The extent to which the applicant

clearly defines objectives and justifies

these objectives in relation to the

proposed focus of the plan to address

priority issues for the malaria-endemic

country RBM program;

d. The adequacy of the plan to carry

out major project components (e.g., in

both the applicant and malaria-endemic

country: leadership, staffing,

administrative coordination, planning,

and measurement activities), including

a timetable that provides major

milestones for implementing activities;

e. The degree to which the plan is

consistent with malaria prevention best

practices and RBM principles;

f. If capacity building for public

health in malaria is proposed, the extent

to which the planned activities relate to

capacity improvements that will benefit

RBM activities in the partner country;

g. The degree to which the applicant

has met the CDC Policy requirements

regarding the inclusion of women,

ethnic, and racial groups in the

proposed research. This includes:

(1) The proposed plan for the

inclusion of both sexes and racial and

ethnic minority populations for

appropriate representation.

(2) The proposed justification when

representation is limited or absent.

(3) A statement as to whether the

design of the study is adequate to

measure differences when warranted.

(4) A statement as to whether the

plans for recruitment and outreach for

study participants include the process

of establishing partnerships with

community(ies) and recognition of

mutual benefits.

4. Evaluation Plan (15 Points)

The extent to which (a) the applicant

describes a detailed plan for monitoring

the implementation of the activities and

evaluating the extent to which the

proposed activities strengthen local and

national capacity for malaria prevention

and control, and (b) the monitoring and

evaluation plan builds on existing

monitoring and evaluation systems in

the project area and can demonstrate

progress towards RBM objectives.

5. Budget (Not Scored)

The extent to which the budget is

detailed, clear, justified, describes inkind or other project support, and is

consistent with the proposed program

activities.

6. Human Subjects (Not Scored)

Does the application adequately

address the requirements of Title 45

CFR Part 46 for the protection of human

subjects? (Not scored; however, an

application can be disapproved if the

research risks are sufficiently serious

and protection against risks is so

inadequate as to make the entire

application unacceptable.)

H. Other Requirements

Technical Reporting Requirements

Provide CDC with original plus two

copies of—

1. annual progress reports;

2. financial Status Report (FSR), no

more than 90 days after the end of the

budget period; and

3. final financial and performance

reports, no more than 90 days after the

end of the project period.

Send all reports to the Grants

Management Specialist identified in the

‘‘Where to Obtain Additional

Information’’ section of this

announcement.

The following additional

requirements are applicable to this

program. For a complete description of

each, see Attachment I of the

announcement in the application kit.

AR–1 Hunman Subjects Requirements

AR–2 Requirements for Inclusion of

Women and Racial and Ethnic

Minorities in Research

AR–9 Paperwork Reduction Act

Requirements

AR–10 Smoke-Free Workplace

Requirements

AR–11 Healthy People 2010

AR–12 Lobbying Restrictions

AR–14 Accounting System

Requirements

AR–15 Proof of Non-Profit Status

AR–22 Research Integrity

I. Authority and Catalog of Federal

Domestic Assistance Number

This program is authorized under

sections 301(a), 307, and 317(k)(2) of the

Public Health Service Act, [42 U.S.C.

sections 241(a), 2421, and 247b(k)(2)], as

amended. The Catalog of Federal

Domestic Assistance number is 93.283.

J. Where To Obtain Additional

Information

This and other CDC announcements

can be found on the CDC home page

Internet address—http://www.cdc.gov

Click on ‘‘Funding’’ then ‘‘Grants and

Cooperative Agreements.’’

To obtain business management

technical assistance, contact: Merlin

Williams, Grants Management

Specialist, Grants Management Branch,

Procurement and Grants Office, Centers

for Disease Control and Prevention,

2920 Brandywine Road, Room 3000,

Atlanta, GA 30341–4146, Telephone:

770–488–2765, Email address:

mqw6@cdc.gov.

For program technical assistance,

contact: Richard W. Steketee, MD, MPH

or Craig Leutzinger, Division of Parasitic

Diseases, National Center for Infectious

Diseases, Centers for Disease Control

and Prevention, 1600 Clifton Road,

Atlanta, GA 30333, Telephone: 770–

488–7760, Fax: 770–488–7761, Email

address: ris1@cdc.gov or cll1@cdc.gov.

Dated: June 22, 2001.

John L. Williams,

Director, Procurement and Grants Office,

Centers for Disease Control and Prevention

(CDC).

[FR Doc. 01–16248 Filed 6–27–01; 8:45 am]

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Center for Disease Control and

Prevention

Program Announcement Number

01163 Correction

AGENCY: Centers for Disease Control and

Prevention, HHS

ACTION: Program announcement number

01163 correction.

SUMMARY: The Centers for Disease

Control and Prevention published

Program Announcement 01163 for HIV

Prevention Projects for CommunityBased Organizations Targeting Young

Men of Color Who Have Sex With Men

FOR FURTHER INFORMATION CONTACT:

David A. Wilson, 770–488–2692

Correction

In the Federal Register of June 21,

2001, in FR Vol 66, No. 120, Page 33254,

first line, third column, correct date to

read On or Before July 31, 2001. On

Page 33255, second column, under J.

Where to Obtain Additional

Information, third paragraph, phone

number for David A. Wilson should

read: 770–488–2692.